The Recall Desk
HighFDA (Devices)·Z-0351-2018·Announced 2018-01-24

Hologic Recalls Affirm Lateral Arm Upright Biopsy Accessory Due to Component Issue

Hologic, Inc. is correcting 12 Affirm Lateral Arm Upright Biopsy Accessories in the U.S. due to a component issue that could impact needle alignment during lateral biopsy procedures.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II and involves a risk-of-harm product where injury has not yet been reported, meeting the criteria for a High severity score.

Plain-English summary

Hologic, Inc. is implementing a product correction for its Affirm Lateral Arm Upright Biopsy Accessory (Product Number: ASY-09880). The recall involves 12 units distributed in the United States and other locations. The affected devices have UDI Number 15420045506817 and serial numbers LAT1200100 and LAT1200165.

The correction was initiated due to an issue with the Left-hand Guide or Blue Needle Guide component. This defect could impact needle alignment for all left-approach lateral biopsy procedures. Consequently, the position of the needle within the breast may be affected, which could impact the aspiration of the intended tissue. The source notes that this impact is case-dependent and detectable when imaging is used to confirm needle position and tissue acquisition during and after a procedure.

There are no known instances of illness or injury associated with this product correction. The agency classifies this as a Class II recall.

The recalled product

Product
Affirm Lateral Arm Upright Biopsy Accessory. Product Number: ASY-09880
Manufacturer
Hologic, Inc.
Affected units
12

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UDI Number: 15420045506817 Serial Numbers: LAT1200100 LAT1200165

Distribution

Distribution scope not specified by the agency.